Form 4: Marimed CFO Converts RSUs, Adjusts Holdings
Insider Transaction Report
Marimed Inc.'s Chief Financial Officer, Mario Pinho, converted 53,571 Restricted Stock Units into common stock and disposed of 15,724 shares for tax purposes on December 31, 2025.
Summary
- Mario Pinho, Chief Financial Officer of Marimed Inc. (MRMD), reported changes in his beneficial ownership.
- On December 31, 2025, Mr. Pinho acquired 53,571 shares of common stock through the conversion of Restricted Stock Units (RSUs).
- Concurrently, 15,724 shares of common stock were disposed of to satisfy tax withholding obligations in connection with the RSU vesting, at a price of $0.0891 per share.
- Following these transactions, Mr. Pinho's direct beneficial ownership of common stock stands at 244,814 shares.
- The RSUs were originally granted on February 18, 2025, and no unvested RSUs remain under this specific grant.
Sentiment
Score: 5
Explanation: The filing reports a routine insider transaction (RSU vesting and tax-related sale) which is neutral in sentiment. It does not indicate any significant positive or negative operational or financial news for the company.
Positives
- The vesting of Restricted Stock Units indicates a successful retention and incentive mechanism for a key member of management.
- The Chief Financial Officer's continued beneficial ownership of 244,814 shares aligns his interests with those of the company's shareholders.
Negatives
- A portion of the shares (15,724) was sold to cover tax liabilities, which, while a common practice, reduces the direct ownership stake.
Future Outlook
This filing is a report of past insider transactions and does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.
Industry Context
This Form 4 filing reports a routine insider transaction involving the vesting of equity awards and subsequent tax-related share disposition. It does not provide information relevant to broader industry trends or competitive positioning.
Stakeholder Impact
- Shareholders: The transaction represents a minor adjustment in insider ownership. The vesting of RSUs is a standard component of executive compensation, aligning management's interests with long-term shareholder value, though the tax-related sale slightly reduces direct ownership.
- Employees (specifically the CFO): The successful vesting of RSUs represents the realization of long-term incentive compensation for the Chief Financial Officer.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date Restricted Stock Units (RSUs) were granted to Mario Pinho. |
| 12/31/2025 | Date of RSU conversion into common stock and subsequent disposition of shares for tax withholding. |
| 01/02/2026 | Signature date of the reporting person on the Form 4 filing. |
Keywords
Marimed Inc., MRMD, Mario Pinho, CFO, Restricted Stock Units, RSU conversion, insider transaction, beneficial ownership, SEC Form 4, stock vesting, tax withholding
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.